Literature DB >> 15800334

Side effects and good effects from new chemotherapeutic agents. Case 1. Gefitinib-induced interstitial fibrosis.

Neil C Nagaria1, Janet Cogswell, Jin K Choe, Basil Kasimis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15800334     DOI： 10.1200/JCO.2005.04.055

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  7 in total

1.  Corticosteroid therapy against treatment-related pulmonary toxicities in patients with lung cancer.

Authors:  Sun Kim; In-Jae Oh; Seo-Yeon Park; Jang-Hyeon Song; Hyun-Ju Seon; Yun-Hyeon Kim; Seong-Hoon Yoon; Jin-Yeong Yu; Bo-Ram Lee; Kyu-Sik Kim; Young-Chul Kim
Journal:  J Thorac Dis       Date:  2014-09       Impact factor: 2.895

Review 2.  Prevention of ER-negative breast cancer.

Authors:  Yuxin Li; Powel H Brown
Journal:  Recent Results Cancer Res       Date:  2009

Review 3.  New targeted molecular therapies for cancer: radiological response in intrathoracic malignancies and cardiopulmonary toxicity: what the radiologist needs to know.

Authors:  Frederico F Souza; Andrew Smith; Cyrillo Araujo; Jyothi Jagannathan; Ciaran Johnston; Kevin O'Regan; Atul Shinagare; Nikhil Ramaiya
Journal:  Cancer Imaging       Date:  2014-07-23       Impact factor: 3.909

Review 4.  Gefitinib in the treatment of nonsmall cell lung cancer with activating epidermal growth factor receptor mutation.

Authors:  Fariz Nurwidya; Fumiyuki Takahashi; Kazuhisa Takahashi
Journal:  J Nat Sci Biol Med       Date:  2016 Jul-Dec

5.  [Osimertinib Re-challenge for EGFR-mutant NSCLC after 
Osimertinib-induced Interstitial Lung Disease: A Case Report].

Authors:  Junjie Gu; Fan Bai; Lan Song; Yingyi Wang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-11-20

6.  Progressive multiple cystic changes in both lungs in a patient treated with gefitinib for lung adenocarcinoma with multiple lung metastases.

Authors:  Yon Ju Ryu; Eun Mi Chun; Soon Nam Lee; Sung Shin Shim
Journal:  Korean J Radiol       Date:  2014-03-07       Impact factor: 3.500

7.  Gefitinib-induced interstitial pneumonia: A case report and review of the literature.

Authors:  Changqin Luo; Meiling Lv; Yuyao Li; Peijun Liu; Jin Yang
Journal:  Exp Ther Med       Date:  2014-01-21       Impact factor: 2.447
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.